Stocks and securities in focus
Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Adamas Pharmaceuticals Inc. | - | - | - | - | - | - | - |
ADTRAN Holdings Inc. | 5.840% | 4.497% | -6.541% | -44.535% | -35.359% | - | - |
Akebia Therapeutics Inc. | 5.260% | 2.324% | -6.856% | 32.058% | 8.959% | -50.117% | - |
AnaptysBio Inc | -0.810% | 26.154% | 27.461% | 24.242% | 26.804% | 17.143% | - |
Anika Therapeutics | 4.070% | 7.563% | 6.667% | 9.402% | 25.490% | -24.260% | -17.192% |
Ardelyx Inc. | 28.120% | 34.723% | 16.633% | 93.717% | 39.758% | 44.250% | - |
Axt Inc. | 17.890% | 22.070% | 18.493% | 28.636% | 60.189% | -57.550% | -20.075% |
Bellicum Pharmaceuticals Inc. | -9.290% | - | - | - | - | - | - |
Biocryst Pharmaceuticals | -1.220% | 6.102% | -3.035% | -46.798% | -25.533% | -53.624% | -39.530% |
Camtek Ltd. | 0.680% | -3.896% | 2.778% | 224.561% | 18.400% | 189.063% | 758.170% |
Coherus Bioscien. | 4.310% | 10.673% | -5.985% | -68.250% | -30.757% | -82.746% | -85.702% |
Cytomx Therapeutics Inc | -0.190% | 174.933% | 116.369% | 167.792% | 195.415% | -41.915% | - |
Deciphera Pharmaceuticals | -0.850% | 74.436% | 68.116% | 91.183% | 57.877% | -34.831% | - |
Durect Corp. | -8.040% | - | - | - | - | - | - |
Geron Corp. | -1.390% | 3.081% | 18.833% | 46.348% | 85.315% | 220.756% | 131.556% |
Heron Therapeutics Inc. | 4.300% | 5.493% | -4.499% | 19.802% | 54.140% | -82.733% | - |
Hitachi Ltd. | 0.690% | 6.133% | 2.746% | 67.868% | 34.666% | 109.424% | 198.026% |
Intra-Cellular Therapies Inc. | -3.030% | -7.246% | 0.787% | 13.879% | -1.840% | 140.421% | 408.744% |
Mersana Therapeutics | 5.870% | 17.410% | -18.279% | -50.646% | 52.133% | -75.496% | - |
Nordex SE | 1.100% | 8.740% | 15.372% | 28.945% | 32.280% | -35.588% | -0.576% |
Sangamo Therapeutics Inc. | 3.900% | 5.702% | -1.250% | -57.625% | -10.711% | -94.059% | -95.005% |
Schoeller-Bleckmann Oilfield Equipment AG | -1.050% | -7.516% | -6.188% | -21.823% | -3.959% | 13.351% | -48.978% |
Spectrum Pharmaceuticals | -4.190% | - | - | - | - | - | - |